ReproNovo (Series A)
Funding Details
Awarder
Inbox
Date Award
May 22, 2025
Vertical
Reproductive Medicine
Funding URL
View Funding Page
Funding Amount
$65,000,000
Company Info
Founding Year
2021
Traction
ReproNovo has two drug candidates in clinical Phase 2 addressing three disease conditions.
Founders
Jean Marie Duvall, Dr. Joan-Carles Arce, BingMei Hao
Market
Women's Health
Location
Lausanne, Switzerland
Coinvestors
Jeito Capital, AXA IM Alts, M Ventures, Ysios Capital, ALSA Ventures
Company Description

ReproNovo is a startup specializing in reproductive medicine and women's health, developing novel therapies for under-addressed indications including male and female infertility and uterine diseases.

Links
Back to HomeBack to Reproductive Medicine DealsView Funding Announcement